Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trialXiaochu Man, Jie Huang, Shujuan Sun et al.|Clinical and Translational Medicine|2024Cited by 6
LEONARDA-2: Lerociclib plus letrozole versus placebo plus letrozole in HR+/HER2- advanced or metastatic breast cancer.Xichun Hu, Shusen Wang, Zhongsheng Tong et al.|Journal of Clinical Oncology|2024Cited by 1